Regenerative medicine includes cell therapies, gene therapies, and tissue-engineered products (e.g. biomaterials), where the therapeutics are referred to as advanced therapeutic medical products (ATMPs). Strict legislations and regulations apply for the manufacturing of ATMPs, and a prerequisite is access to a clean-room laboratory where cells can be grown and manipulated under very clean and controlled conditions, before they are administered to the patient as an advanced cell-based drug.